Business
PEXA.B: Revenue up, losses narrowed, and a guaranteed rights issue launched to fund clinical expansion
PEXA.B: Revenue up, losses narrowed, and a guaranteed rights issue launched to fund clinical expansion
About this update from Pexa Ab Class B
Revenue and net loss improved year-over-year, with a sharpened focus on early diagnostics and clinical applications. A fully guaranteed rights issue is underway to secure funding, while new partnerships, patent filings, and international exposure support long-term growth.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.